ASCEND BY NTHRYS
Research Abroad Products

Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 210 project topics
Comparative Efficacy and Health Economics Modeling Software for Oncology
A business intelligence platform that models real-world drug effectiveness, cost-effectiveness, and pricing strategies for cancer treatments against competitors. Supports reimbursement negotiations, informs pricing strategies generating millions in incremental revenue per drug launch.
Oncology Pharmacology Drug Development Tools Click to view more details →
Synthetic Patient Cohort Generation and Simulation Technology for Trials
An advanced AI platform that creates realistic virtual patient populations for simulating oncology drug trial outcomes before recruitment begins. Reduces clinical trial uncertainty, enables faster go/no-go decisions, and monetizes through enterprise licensing to major pharmaceutical companies.
Oncology Pharmacology Drug Development Tools Click to view more details →
AI-Powered Antimicrobial Resistance Prediction SaaS Platform
A cloud-based platform that uses machine learning to predict bacterial resistance patterns and identify novel drug targets before clinical testing. Enables pharmaceutical companies to reduce R&D timelines by 40% and de-risk compound selection, generating licensing revenue and accelerating time-to-market for new antibiotics.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
High-Throughput Pathogen Screening Service for Drug Discovery
A commercial screening service that rapidly tests drug candidates against diverse pathogenic organisms and resistance profiles using automated platforms. Delivers recurring revenue through fee-for-service contracts with pharma companies seeking faster, more comprehensive efficacy validation.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Digital Biomarker Discovery Platform for Infection Diagnostics
A SaaS tool that identifies and validates biological markers for infectious disease diagnosis using multi-omics data analysis and AI algorithms. Captures market value through subscription licensing to diagnostic companies and pharmaceutical firms developing companion diagnostics for anti-infective therapies.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Microbial Target Validation and Druggability Assessment Tool
An industry software platform that computationally evaluates bacterial, viral, and fungal targets for tractability and commercial viability before expensive experimental validation. Monetizes through enterprise licenses and API integrations that reduce target attrition rates and improve hit-to-lead progression efficiency.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Real-Time Antimicrobial Stewardship Decision Support System
A clinical SaaS platform integrated into hospital systems that recommends optimal antibiotic selection based on patient-specific factors and local resistance epidemiology. Generates revenue through hospital subscriptions, improves treatment outcomes, and enables pharma partners to gather real-world effectiveness data for market expansion.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Synthetic Biology Platform for Engineered Antimicrobial Compounds
A proprietary design and manufacturing service that uses synthetic biology to create novel antimicrobial agents with customized properties and reduced resistance risk. Delivers value through cost-per-molecule fees, licensing deals, and co-development partnerships that accelerate time to clinical candidates.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Pharmacokinetic-Pharmacodynamic Modeling SaaS for Infection Treatment
A cloud platform that builds predictive PK-PD models for anti-infective drugs to optimize dosing regimens and patient outcomes using clinical and preclinical data. Generates B2B revenue from pharmaceutical companies conducting clinical trials and regulatory agencies seeking evidence of therapeutic efficacy.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Viral Genome Sequencing and Variant Prediction Commercial Service
A next-generation sequencing service platform that rapidly identifies viral variants and predicts treatment response to antiviral drugs at clinical scale. Monetizes through per-sample testing fees, subscription models for public health agencies, and data licensing agreements with pharmaceutical firms.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Multi-Pathogen Drug Interaction and Efficacy Database Platform
An enterprise data platform aggregating comprehensive drug-pathogen interaction profiles, resistance data, and clinical outcomes across millions of patient records. Generates recurring SaaS licensing revenue while providing pharma and healthcare organizations with competitive intelligence for market positioning and treatment protocol development.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →
Computational Structure-Based Anti-Infective Design Workflow Software
An integrated software suite that leverages structural biology and computational chemistry to design novel inhibitors targeting pathogenic proteins with minimal off-target effects. Delivers revenue through perpetual and subscription licenses to medicinal chemistry teams, reducing synthesis cycles and improving drug candidate quality.
Anti-Infective Pharmacology Discovery Platforms Click to view more details →